Traders sold shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) on strength during trading on Monday. $44.53 million flowed into the stock on the tick-up and $170.94 million flowed out of the stock on the tick-down, for a money net flow of $126.41 million out of the stock. Of all stocks tracked, iShares Nasdaq Biotechnology ETF had the 0th highest net out-flow for the day. iShares Nasdaq Biotechnology ETF traded up $2.06 for the day and closed at $119.46

Several hedge funds have recently modified their holdings of the business. Millennium Management LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF in the 4th quarter valued at $1,127,000. Ashfield Capital Partners LLC lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 8.6% in the 1st quarter. Ashfield Capital Partners LLC now owns 45,478 shares of the financial services provider’s stock valued at $4,854,000 after acquiring an additional 3,599 shares during the last quarter. Paradigm Financial Advisors LLC lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 8.5% in the 1st quarter. Paradigm Financial Advisors LLC now owns 25,598 shares of the financial services provider’s stock valued at $2,732,000 after acquiring an additional 2,009 shares during the last quarter. Daiwa Securities Group Inc. bought a new position in shares of iShares Nasdaq Biotechnology ETF in the 1st quarter valued at $265,000. Finally, D.B. Root & Company LLC lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 45.2% in the 1st quarter. D.B. Root & Company LLC now owns 4,185 shares of the financial services provider’s stock valued at $447,000 after acquiring an additional 1,302 shares during the last quarter. 64.86% of the stock is currently owned by hedge funds and other institutional investors.

iShares Nasdaq Biotechnology ETF Company Profile (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: Diversification in Your Portfolio

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.